160 related articles for article (PubMed ID: 11485181)
1. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination.
Ennis RD; Pritchard R; Nakamura C; Coulon M; Yang T; Visor GC; Lee WA
Pharm Dev Technol; 2001 Aug; 6(3):393-405. PubMed ID: 11485181
[TBL] [Abstract][Full Text] [Related]
2. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
[TBL] [Abstract][Full Text] [Related]
3. Determining the delamination propensity of pharmaceutical glass vials using a direct stress method.
Sloey C; Gleason C; Phillips J
PDA J Pharm Sci Technol; 2013; 67(1):35-42. PubMed ID: 23385562
[TBL] [Abstract][Full Text] [Related]
4. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
[TBL] [Abstract][Full Text] [Related]
5. Impact of Vial Washing and Depyrogenation on Surface Properties and Delamination Risk of Glass Vials.
Ditter D; Mahler HC; Gohlke L; Nieto A; Roehl H; Huwyler J; Wahl M; Allmendinger A
Pharm Res; 2018 May; 35(7):146. PubMed ID: 29796727
[TBL] [Abstract][Full Text] [Related]
6. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
Hladik B; Buscke F; Frost R; Rothhaar U
PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Acid Titration, Conductivity, Flame Photometry, ICP-MS, and Accelerated Lamellae Formation Techniques in Determining Glass Vial Quality.
Fujimori K; Lee H; Sloey C; Ricci MS; Wen ZQ; Phillips J; Nashed-Samuel Y
PDA J Pharm Sci Technol; 2016; 70(3):248-55. PubMed ID: 27091889
[TBL] [Abstract][Full Text] [Related]
8. Characterization of surface properties of glass vials used as primary packaging material for parenterals.
Ditter D; Mahler HC; Roehl H; Wahl M; Huwyler J; Nieto A; Allmendinger A
Eur J Pharm Biopharm; 2018 Apr; 125():58-67. PubMed ID: 29331438
[TBL] [Abstract][Full Text] [Related]
9. Development of Conductivity Method as an Alternative to Titration for Hydrolytic Resistance Testing Used for Evaluation of Glass Vials Used in Pharmaceutical Industry.
Fujimori K; Lee H; Phillips J; Nashed-Samuel Y
PDA J Pharm Sci Technol; 2017 1/2; 71(1):50-58. PubMed ID: 27593692
[TBL] [Abstract][Full Text] [Related]
10. Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.
Nashed-Samuel Y; Gastwirt J; Kotia RB; Moore S; Masatani P; Torraca G; Goss M; Dolan DG; Akers M; Padala C; Wypych J; Semin DJ
J Pharm Sci; 2022 Dec; 111(12):3275-3286. PubMed ID: 36116524
[TBL] [Abstract][Full Text] [Related]
11. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.
Guadagnino E; Zuccato D
PDA J Pharm Sci Technol; 2012; 66(2):116-25. PubMed ID: 22492597
[TBL] [Abstract][Full Text] [Related]
12. Delamination Propensity of Glass Containers for Pharmaceutical Use: A Round Robin Activity Looking for a Predictive Test.
Cerdan-Diaz J; Choju K; Flynn CR; Gavioli L; Iacocca R; Meysner A; Pfeifer J; Roehl H; Rupertus V; Scarpa M; Sun H; Zhang J; Zuccato D; Guglielmi M
PDA J Pharm Sci Technol; 2018; 72(6):553-565. PubMed ID: 29954923
[TBL] [Abstract][Full Text] [Related]
13. Glass delamination: a comparison of the inner surface performance of vials and pre-filled syringes.
Zhao J; Lavalley V; Mangiagalli P; Wright JM; Bankston TE
AAPS PharmSciTech; 2014 Dec; 15(6):1398-409. PubMed ID: 24938618
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the chemical durability of glass used in the pharmaceutical industry.
Iacocca RG; Toltl N; Allgeier M; Bustard B; Dong X; Foubert M; Hofer J; Peoples S; Shelbourn T
AAPS PharmSciTech; 2010 Sep; 11(3):1340-9. PubMed ID: 20740334
[TBL] [Abstract][Full Text] [Related]
15. Investigating factors leading to fogging of glass vials in lyophilized drug products.
Abdul-Fattah AM; Oeschger R; Roehl H; Bauer Dauphin I; Worgull M; Kallmeyer G; Mahler HC
Eur J Pharm Biopharm; 2013 Oct; 85(2):314-26. PubMed ID: 23791681
[TBL] [Abstract][Full Text] [Related]
16. A case study demonstrating the importance of glass vial selection for parenteral pharmaceutical products.
Sperry A; Imhoff D; Traunfeld J; Gundagari S; Smaga K; Singh G
J Pharm Sci; 2024 Jun; ():. PubMed ID: 38880302
[TBL] [Abstract][Full Text] [Related]
17. Nondestructive detection of glass vial inner surface morphology with differential interference contrast microscopy.
Wen ZQ; Torraca G; Masatani P; Sloey C; Phillips J
J Pharm Sci; 2012 Apr; 101(4):1378-84. PubMed ID: 22234873
[TBL] [Abstract][Full Text] [Related]
18. Fill volume as an indicator of surface heterogeneity in glass vials for parenteral packaging.
Kucko NW; Keenan T; Coughlan A; Hall MM
J Pharm Sci; 2013 Jun; 102(6):1690-1695. PubMed ID: 23558423
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Glass Delamination Risk in Pharmaceutical 10 mL/10R Vials.
Ditter D; Nieto A; Mahler HC; Roehl H; Wahl M; Huwyler J; Allmendinger A
J Pharm Sci; 2018 Feb; 107(2):624-637. PubMed ID: 28989023
[TBL] [Abstract][Full Text] [Related]
20. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]